James George Chopas - 31 Aug 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Issuer symbol
APLS
Transactions as of
31 Aug 2023
Net transactions value
-$22,716
Form type
4
Filing time
01 Sep 2023, 16:08:14 UTC
Previous filing
22 Feb 2023
Next filing
18 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $22,716 -551 -1.8% $41.23 30,312 31 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on a Restricted Stock Unit release.